FDA Approves Unknown Drug — EMD SERONO INC
On March 23, 2017, EMD Serono received FDA approval for the drug, a move which positions the company to capitalize on increased demand within this therapeutic segment while enhancing its portfolio and shareholder value.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed